PFE

RevolutionaryPhoto24

I bought my first ever ETF today. Well, sort of. Wrote puts on VT (and PFE & BRKB.) What is happening?!?

Justanunknownauthor

You dumped NVDA for PFE?

ETFBro4DaWinz

Probably will just keep accumulating PFE if there's an aggressive sell-off again.

wolvendael

So this is gaslighting 101 by a VKTX baggie. No stock has a bigger cult following than VKTX. How many times have you heard of ALT? My guess is few and far between - hence it doesn’t pass the smell test that it has a cult following. ALT does have a few followers who objectively look at very good science and differentiating factors that continue to be ignored by WS and bashed by competitors. The truth about pemvidutide: it’s a 1:1 glucagon to GLP agonist, which skews it less towards max weight loss (-15% in its straight obesity trial) and better suited for MASH. It had its phase 2 results (which weee excellent) published in The Lancet, has late-breaker podium presentation at the largest hepatology conference in Nov, receive BTD from the FDA for phase 3, has a new commercially-focused CEO, and is now likely in talks with a partner. Yet it barely sits above cash value. That is what ALT investors are focused on - the mispricing or deliberate suppression of the share price. The competitive landscape favors pemvidutide: it has the classic MASH and fibrosis response of other drugs in its class, but it has BIC tolerability. This is what matters most in MASH: staying on the drug. Hepatologists and GIs have repeatedly said that they are not chasing weight loss. It’s nice to have, but GLP1s that have 10-20% diacontinuations (like survodutide) are not going to be prescribed. Patients have a serious liver disease and have to remain on the drug. Pemvi has <1% tolerability, mainly due to its EuPort construction, which slows absorption and decrease max concentration. This is a large differentiating factor for pemvi. After that, its results with prescriber-preferred noninvasive tests (VCTE, ELF, PDFF) were so good and statistically significant that the global head of MASH for Lilly called them “beautiful” at AASLD conference in Nov. and now FDA is moving away from biopsy and allowing NITs for pivotal trials - right at the perfect time for ALT’s p3 design. ALT bulls aren’t trying to convening you that pemvidutide will be the number 1 drug of all time, or that it will replace all other MASH drugs. It’s simply that pemvidutide does seem poised to capture a lot of the market, has been derisked due to FDA BTD (conferring a historical 80% prob of success from a Jefferies analysis), and that every other drug entering p3 in MASH with good data and BTD has been bought for $3bn to $5bn. It’s a hot field. There are many legacy players with no presence - including GSK, AZ, PFE, and many others looking to get into the MASH field. ALT longs would simply like to see the company rerate to fair value. It’s certainly long overdue.

2Hosslovescash

NVO borrowed PFE’s best pill.

Negative_Win_5117

Yeah. I trade spreads all the time but legging into your own spread on something as boring as PFE and making 100% is wild.

No-Improvement3164

Whys there so much volume on the January 2028 ITM calls on PFE today?

dvdmovie1

In 2023 people kept advocating for PYPL on here saying "it's cheaper than NVDA" and then people kept trying to buy the PYPL dip on here in 2024, then in 2025 and now again in 2026... at some point it starts to feel like people don't want to actually look for new ideas and just keep copying others/going back to the same set of things when they don't want to buy growth. See also: frequently mentioned PFE, which has been a "buy the dip" mention on here for years too, like in 2023 when I was frequently told that it was a better buy than LLY because "PFE is cheap and they have an obesity drug too." The obesity drug was a failure, PFE has an atrocious record over the last couple of decades and yet, because it's a household name, it has a high dividend yield and a low p/e that somehow allowed people on here to overlook the incredibly lackluster track record the company has had over the last 20 years or so. Hopefully for all the bagholders it gets sold somehow. Otherwise, at this rate I'm sure we'll continue to be regularly informed of the case for PYPL in 2027, 2028 and 2029.

GhostofBreadDragons

PFE is a good safe stock to hold. That dividend is very appealing and stable in a world that isn’t.  Then you just wait for their next big thing while collecting 6%

dvdmovie1

It's already broken out. XBI had a good year last year for once in a long while - in recent years, it's seemed as if the category broadly struggled while you could do well if you picked a narrow group of right names. I had four names bought out last year. Biotech is incredibly risky and it depends on what you're looking for. If you're looking for GLP-1, there's LLY in the lead, NVO and a lot of also-rans that might get bought in the manner that PFE overpaid for MTSR. People also don't talk about aesthetics - I've done well with diversified dermatology co GALDY in the last year.

EngineeringOptions

Why can't you? It would make more sense to get some experience using low priced tickers like F, PFE and so on. Big ETFs like QQQ and SPY will have you tying down at least 50k in a position

DisastrousPlantain51

So why would this stock in your opinion go to 100 from 6 dollars? Compared to NVO PFE MRK other related pharma stocks?

Punchmeinmyface25

Get PFE

dvdmovie1

Some of these are value traps imo, but I think there's also a patience issue when you go full port "cheap stocks" in a market like this rather than having it be a part of a portfolio. It's rare that I see people that have some exposure to value and some to growth - people seem to have to be in one tribe or the other and when they go fully into one tribe they often talk down the other. In 2023, people on here were incessantly pumping PYPL because it was "cheap" and NVDA had "gone up too much." We all know what NVDA did since, while PYPL has gone largely nowhere. All the discussions in 2023 how people should buy PFE instead of LLY because it was "cheap and had an obesity drug too." A couple of years later, PFE is below where it was and the obesity drug in question was a failure. People keep treating something like PYPL as if the fintech theme is what it was 4-5 years ago. People keep talking up PYPL down 76% in 5 years and the company formerly known as Square is down 70% in the same time frame. Not saying these aren't optically inexpensive but when both names have done absymally during a fantastic period for growth, I think what I don't agree with are these unbalanced takes that "everything is great with this company and nobody gets it." At some point this may attract a bit more attention if people turn towards value, but after three years of hearing about how cheap this is on here isn't there a point where people think maybe this is cheap for a reason? "Adobe, Forward PE of 13 and everyone uses it (also most likely to integrate AI, likely hug rally on that)" It is argubly cheap but that's not a thesis and you don't address the concerns that have gotten it to the point it is. How many other AI image generation tools are out there now? If ADBE sells seat based software to an ad agency and there's less need for as many people to do the same tasks because of AI, what happens to something like ADBE? Lately it's gone beyond ADBE and a lot of software names have struggled in recent months, too.

Negative_Win_5117

Even my Boomer shit is mostly green even before accounting for dividends - MO, LMT, CVX, UPS, INTC. A few losers in there like PFE and PYPL but I feel like I can’t hardly lose. Now I’m nervous.

No-Improvement3164

Why does PFE stock even exist?

BahnMe

Of course like an idiot I bought PFE instead a couple months ago since they were so “undervalued”. Maybe they’re “undervalued” because they’re incompetent.

Happy-Champion1661

PFE pumping

AlGAdams

Im in SPY, SCHD, AMZN, MU, KSPI, PFE at a yearly P/L of 34.5% with additional yield from CC sometimes. But yeah Im considering 100% in Beyond meat 

Punchmeinmyface25

PFE cure cancer and fat

ShareholderSLO85

I have hopes for PFE, MRK and BMY.

yellowstickypad

Whoever called out PFE calls for 1/16, bless you. (No chance I find the original comment in a WSB thread this week)

Thisispaartaaa

PFE calls it is!

Choice-Shame2035

I’d add PFE, I own it just because of their nice div, but def don’t like the company.

BigWarning8696

PFE has awful management

PaperHandsTheDip

leaps are boring tho, so maybe just full port weeklies and pray ¯\\\_(ツ)\_/¯ I've been in & out of PFE a few times. Seems relatively stable around here, not much downside imo. Might take a while to recover tho. Solid div if you're into the shares tho

RangerAdmirable9102

Eh. I was highly invested in all the big tech names before April. After the dip, my portfolio was down over 20%. I sold during the recovery, some at a loss, some at a gain. Most of those are much higher than they were. But I divested from Tech and started focusing on value and stocks with more growth runway. My portfolio is up 50% from April and 25% since October. I sold “winners,” and I think most people would regret selling like I did. I see it as freeing up capital for other price movements and I have a mix of solid companies with nice dividends (like PFE and KMB, to help me weather the bad days) and growth stocks like ASTS and RKLB. Im avoiding AI. Yes, I see the growth potential, but I also think there’s a lot of financial manipulation, pre revenue companies that are all hype, and companies that won’t be profitable for years trading at obscene multiples.

Historical-Radio-349

PFE you’ll be in time for the 1/23 ex div

corundum9

CVX, XOM, NKE, PFE, and DOW/LYB if you think chemical markets will cyclically improve

wylekebber

I would drop oil; it's organic and not as difficult to produce as lobbies would previously had us believe and nicotine is a nootropic. Food processing $PEP, $KHC, $TSN and pharma are much more mischievous imo; $JNJ, $LLY, $PFE. Or you could just have a portfolio of 100% T-bills and loan money to the US Government.

Unable_Illustrator_2

Pfizer (PFE)

Excellent-Mud2091

Dick pills was all you had to say. Calls on PFE

TheInkDon1

You're welcome. And well, you know how long Calls work I think, right? Because you're thinking of buying them on PFE. Do you know how CCs work? I mean, beyond, "I can sell these and get some cash"? Have you ever taken the time to figure out what the Return on Investment or Return on Capital is? (There's probably an esoteric difference between those 2 terms, but I just tend to use ROI: if *this* much is at risk, and I made *that* much, then how much did I earn as a *percentage*?) You're thinking of selling CCs against your Pfizer shares, so let's start there. Share price (spot) is 25.18. It's generally recommended to sell CCs at 30-delta or less, 30-45 days out (TastyTrade and others say that.) But 28 days isn't too much of a stretch so let's use that, 4 weeks. (And being it's the weekend now, it means I don't have to go out to 5 weeks, 35DTE, to stay inside 30-45 days.) Pfizer has $1-wide strikes, a bit unusual when sot is 25, so we get to choose 26-delta or....ITM. So we choose the 28DTE 26-delta 26C selling for 0.19. To calculate ROI, simply divide by the share cost, so: 0.19 / 25.18 = 0.75% in 4 weeks There are 13 4-week periods in a year, so x13 to get 9.8%. Decidedly underwhelming. But don't forget the 6.9% dividend yield, so add to get 16.7%. And now you've almost exactly matched what SPY did over the past year, 16.8% over the past year. And for very little work, just 5 minutes of selling a Call once a month. But then, why not just invest in SPY for zero extra work. But you're considering selling Pfizer, yes? So what if you sold the just-ITM 25C's for 0.59? That would be you saying, "I'd be fine with letting these shares go for $25, but in the month until then, I'll take the 41-cent extrinsic/theta value of those Calls and put it in my pocket. So then you get to divide that 0.41 'real' Premium (because 0.18 of the 0.59 cost was just the buyer paying for equity in PFE) by 25.00 (the strike price) to get: 0.41 / 25 = 1.64%. Apy to 21.3%, add the 6.9% dividend yield to get 28%. And that's quite spiffy! But how would you get that without having your shares called away? 1) By having PFE close below 25 in 4 weeks (just a 0.7% drop). Or, 2) Buying back that short Call when it's lost half its value. Because that's how we're "supposed" to do those. So you see, **if PFE will just stay flat**, you could do that about every 2 weeks, earn half that premium. And 26 times of getting half of something is the same as getting the whole something 13 times. Now, make sure I've got your full attention, because **this is where the magic happens.**

TheInkDon1

It's too funny you mentioned LEAPS Calls on Pfizer today! Here's why: I had an email from US News & World Report this morning about the 9 highest dividend-paying stocks in the S&P. (Why they didn't pick 10 I don't know; just to stand out a bit?) And since I hadn't checked on dividends lately, I had a look. They were about what I expected: 6.6% up to 12.6%. Though tbh, I wouldn't have guessed over 10%. I'm not a dividend investor. But I AM a PMCC trader, so I thought, "Let me see if any of these are stable enough that they don't lose value while I write 2-4 week Calls against them." Verizon was the first one to pass that screen, but Pfizer was next, down 5% over the past year, but mostly flat on the 6-month, 3m, and 1m views. To answer your specific question: I wouldn't be buying Pfizer LEAPS Calls for speculation. It's chart just doesn't support it, to my eye. **But as a stable base for selling Premium against?** Let's look at that. I buy LEAPS Calls (for speculation) just a year out, and not less than 80-delta. Here that would be the Jan'27 20 Calls at 86-delta for **5.40**. I sell Calls just 2 weeks out, and nominally at 30-delta. But if Pfizer isn't going to move, then why not right ATM? The 16Jan25.5C's at 38-delta are selling for **0.24**. ROI: 0.24 / 5.40 = 4.4% in 2 weeks. And that's pretty spiffy! Because that apy's to 115%. Okay, but what did I leave out of the "which LEAPS Call to buy" discussion? The time value I'd be paying for. It's 0.21, or $21 over the 378-day life of the Call. 5.5 cents per day. 1) That's very low, as these things go. Just 4% of the cost of the Call. Compare that (at the same Delta) to other tickers I trade: 12.5% for XBI, and 19% for SLV. 2) Just 1 sale of a 2-week Call more than pays for it. I can live with that. Because going out farther in time, and/or higher in Delta, to minimize theta-per-day, also makes the denominator of the ROI calc larger, reducing that theoretical 120% apy return. And remember too that PFE could go down, and we'll want that premium to buffer that. And because I put my money where my mouth is: [I took that position](https://imgur.com/a/IwxD3GX) Just an exploratory $500 position, but I may expand on that. And/or add similar trades from dividend-paying stocks I like. Sorry for all the words, but I had to go where that took me. Take care.

Crew4815162342

https://preview.redd.it/yha11hw7yzag1.png?width=1135&format=png&auto=webp&s=824e65e09fdba7137ab2c014cf8f364f508e5387 Seagen being the closest. $PFE has also requested meetings with Angelo's the CEO of $SLS

panda-money-um

Big pharma. PFE is a great one

RanDumbPlay

Why PFE?

its_fkn_hot_here

Seems like you need some drug companies on here. I nominate PFE.

Reasonable-Guest2392

Okay, the comments aren’t really helpful technically, but also helpful realistically. So as a new investor myself, 2 things I learn are 1)high reward comes with high risk, but high risk doesn’t necessarily contribute to high reward. 2)Everyone has a tolerance, and the right approach is unique. So set your own expectations. Personally for me 12-15% annual return! I tried to test different approaches (whatever comfortable). I tried to DCA FZROX and FZILX and small cap FZIPX for some months, and I didn’t know the small cap and sold for like 2% profit. I also tried to high dividends stocks due to recent price sink, like UPS, target, and high reputation PEPSI, also came across Verizon and PFE. So for those stocks, I buy gradually as well, I only add more if they sink, and when they rise like 5% in a week or so, I’ll sell, cuz annual returns already past my expectations 12-15%! I did hold a couple of times, for example Pepsi, reached 7% in 2 weeks but 2% still before I sold after 3 months! You do the maths. All above just make me stay in the track! The bonus is when I trade coreweave! When they tank like 20% in a week, I started to buy little by little, and when it pops up, I sell after couple of days, once made 12% and another time 22%! So the key for my “day trade” is NOT greedy! Buy dip sell high ONLY! Hope it helps. Good luck to all of us in 2026!

IntentionDeep651

PFE avoiding tariffs than hiking the price anyway , lmao they played everyone 

PatFlynnEire

Split it among CRMD, BFLY and PFE and write monthly calls on PFE.

AlGAdams

Bought and sold CVX AMZN DELL VISA META CRWV MU Holding into 2026 AMZN PFE KSPI MU UNH Trying to increase positions in PFE and UNH

RealityAddict333

PFE

IDrinkSulfuricAcid

Oh boy, there's much better dividend stocks! You could go with Verizon (VZ) which has a 6.82% dividend. Altria (MO) has a 7.36% dividend. 6.86% on Pfizer (PFE). Western Union (WU) offers a 10% dividend. Obviously the drawback is that a lot of these stocks don't grow or some are actively going down. Chevron has a relatively lower dividend compared to these, but it's stable. From these, I would choose VZ.

Lazy-Gene-7284

I agree on that part, just not sure you need “ bonds” or dividend bearing equivalents at your age. I retired a year ago and 20-25% on my holdings are now in dividend payers like VZ , PFE and others, with 10-15% in money markets and bonds. Yields are a lot better and they have some potential upside as rates turn lower

sudharsansai

Calls on PFE

obee1can

$PFE

LoveLaughterPizza

PFE

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

InternetIsntMyFrend4

Plus you need to pay taxes on your Capital gains.  You should look into dividend income from SCHD or companies like PFE.

BLVCKYOTA

Oh PFE is green, that’s why things are stalled.

KawaiiGeorgiaPeach

25yo student with no job. I have had a portfolio since 2023. I was given most of this by my father and don’t know where to start looking for advice. I bought VTI, VXUS, and BND after reading about 3 fund portfolios. What do I move around? Need to maximize growth so I can afford food while in school. Can’t afford much risk now. KO 2 shares SLV 1 share PFE 50 shares bought by grandfather in the 1960s SPYM 3 shares since I can’t buy fractional VOO VOO 38 shares BND 2 shares have not made money VXUS 2 shares VTI 3 shares

AluminiumCaffeine

I dont know pharma well for NVO/PFE, I dont understand how NVO is so cheap but the market seems to be set on smashing it down. NKE I dont follow closely but its tough in retail with rises and falls ala LULU. could work for sure though if it got its stride back

Able_Show_8560

what are your thoughts then on NVO, NKE, or PFE?

just-one-jay

I’ve been successfully doing this and have made a ton of money this year, I got stuck in a monster PFE position betting the admin would back off vaccines, that or a health crisis would occur thanks to brain worms and the money would pile in. I’m still long on PFE, and my medical vaccine investing really paid off with MRNA and GSK. At least PFE pays a sweet divvy

Lazy-Gene-7284

There are some things that’ll go down much less or even appreciate, stocks like VZ and PFE with higher yields and predictable cash flows can be safe(r). At your age just keep firing at the pin, but if it makes you feel better promise yourself you’ll go all in when it drops 20, 25, 49%. Chances are you’ll be too scared right then and miss it.

Revolutionary-Tie263

XLO, LUCY, IGC, AEYE, some smaller companies I’m looking at now. CWT is a safer stock I may look to buy closer to $42, PFE is on my radar.

Real-Instruction2029

I have positions in SOFI, NOK, CSCO, ORCL, PFE, VLO

InfamousHedgehog691

You're missing numbers from this thesis.  What's their revenue breakdown?  Where are they targeting growth and what's the range/likelihood of outcomes? Good cash on the sheet, but they look to be bleeding money.  They have been losing lots of money every of the past two years.  Why and what's the expected return?   If they are so attractive why didn't they get scooped up yet?  PFE just went on a huge shopping spree and they know MRNA well.  BMY also has been in M&A for oncology.  

AlGAdams

AMZN, PFE, KSPI, MU, META Index ETF: SPY, SCHD

HanzDiamond

hey while you're at it how bout some help with these PFE bags?

Low-Mirror7154

PFE or NVO, healthcare in general, but especially those which pay a dividend, have products and have been out of favour. Dividend not just for the cash, but rather as proof that the company a) makes profit and b) is willing to distribute that to shareholders.

PeddyCash

April PFE 27c hopefully guna print

PeddyCash

Loaded up on PFE 4/17/26 27c today. How regard how I

No-Improvement3164

PFE sitting at 25.02 so the calls I have sold don’t expire worthless. Oh the games they play with me

AlGAdams

100 shares MU at 250, OR 1000 shares PFE at 25?

PaperHandsTheDip

They're not a bad idea - as they have lower IV's and so calls are cheaper. Last time I played calls on PFE I made \~50% returns in a single day. PFE is one of those you can buy leaps on - and if it goes up by even \~5% in the next year you more or less make \~50-60% returns on capital.

askepticoptimist

Calls on a dividend stock are a bad idea. You have the natural force of distributions pulling this price constantly down, and this isn't a tech growth stock that can make up the difference. PFE is at a good entry point for a stock purchase on a long-term hold, but calls are something I'd avoid.

noodle_lo

Beginner investor here and would love your perspective. I bought 250 shares of PFE at \~$43 USD back in 2020/21 (about $10k total). It’s now around $25, and my all-time return shows -$4,500. I’ve basically just held it this whole time hoping it would at least recover too. With todays news about lower COVID product sales and articles saying “Pfizer stock could sink more”, I’m wondering how much weight people actually give to this kind of news vs just ignoring the noise. At this point, does it make sense to keep holding because I’m already so far down, or is that just sunk-cost thinking?

noodle_lo

Beginner investor here and would love your perspective. I bought 250 shares of PFE at \~$43 USD back in 2020/21 (about $10k total). It’s now around $25, and my all-time return shows -$4,500. I’ve basically just held it this whole time hoping it would at least recover too. With todays news about lower COVID product sales and articles saying “Pfizer stock could sink more”, I’m wondering how much weight people actually give to this kind of news vs just ignoring the noise. At this point, does it make sense to keep holding because I’m already so far down, or is that just sunk-cost thinking?

SolubleAcrobat

PFE

just-one-jay

I’m long PFE… boomers gotta blow their wad on over priced medical care somewhere

AlGAdams

If you sell CC monthly around 15% OTM you can easily yeild 10%+ APY with PFE

Top_Ad_5339

KHC, PFE (just barely) and MWP

PaperHandsTheDip

I played leaps / calls a few times. The IV is insanely low - so anything "up" just prints. But you gotta ignore intermediate noise. \--- I've had 4-8k PFE calls over the last few months. Expiration 6-12 months. Hence why I played short term - it was on my radar. Fun little ticker!

the_humeister

PFE

worst_items_instock8

I don't know about options necessarily but PFE under 25 is a Christmas gift

sobanspirit

NGL, I don’t understand the hate towards this stock. Business fundamentals are solid. There is a lot that goes into a stock, but on a pure EPS play you are not going to find many stocks that beat PFE that has bond levels of dividend performance which if things bomb for the stock in a worse case scenario they are likely to just hold and not cut. This stock has a sky high dividend rate for a company 100+ years old. It has survived recessions and depressions and it acquires new biotech in line with industry standards. We can have a debate on their internal innovation, but for a company with EARNINGS in the 10+ billions of dollars range they can probably buy their way out of every patent cliff they have and are actively diversifying their product pipeline as well as investing in LLM partnerships that will keep them current when personalized medicine becomes a reality. I’ll be honest with my vision for this. I hope you all sell. I hope this stock drops below $20 so my DRIP buys me more stock than it would at 40. I’m not selling for the foreseeable future if ever. I’d rather stake my financial future and that of my family on a stock with a solid financial sheet that the public hates for XYZ reasons than just investing in the latest crypto trash or meme stock with an EPS over 30. Do I want PFE to bounce so option traders get a buck? No. Honestly I’d rather you short the stock. Please, from the bottom of my heart prove me wrong. I’ll post on wallstreetbets when everyone shows me the error of my ways. Until then I’ll trust in my understanding of biotech.

Happy-Champion1661

AH usually not relevant with PFE tho, always extremely low volume we'll see tomorrow at open if they try to push it back up a quick 0.5-1%

PaperHandsTheDip

Pretty much. If it's > 50 I'll play with much longer expirations (often leaps) to minimize iv crush. If it's > 100 I often won't even play. I looked at TSLA and it's not actually thaaat bad (sitting \~50). \--- For tesla - you need a 2% drop to breakeven by friday and another 2% drop to double up. On PFE here, I need a 1% bull to breakeven and another 1% to double up.

Untilretirement

you are right about PFE calls dropped to 8-9 cents. what do you consider super high IV? anything above 50?

PaperHandsTheDip

TSLA has super high IV tho. That makes it unappealing for me to gamble on - because a correct bet doesn't pay well. Low IV -> correct bet pays huge sums. These calls are up almost 250-300% since the bottom. Look at the PFE chart today. The calls bottomed \~8cents iirc

Zonagilamonster

I bought PFE for about that price over a decade ago, sold in the 50s during covid. what a dog

PaperHandsTheDip

Bought PFE calls that expire friday for no reason other than it dropped a lot today and IV was low ¯\\\_(ツ)\_/¯

AlGAdams

Wish PFE would go sub 24.5 soon

Same-Brilliant2014

Didn't burry buy a bunch of PFE? 😬

deevee12

PFE defends about well as a cardboard fortress

dvdmovie1

There's also countless other, better healthcare companies than a company that has done horridly over both the short and long-term that has a lousy track record with M&A including about 5.4B on GBT (whose drug was eventually pulled) and getting bid up by NVO recently for MTSR. PFE on here feels like it's the healthcare name so many people go with simply because it's the healthcare name they've heard of. It's like O and REITs - if someone mentions a REIT on here there's about a 90% chance it's that - people just going with what they read everyone else owns.

No-Improvement3164

All I have to do is touch PFE and that piece of shit drills. WTF!!

drew-gen-x

Sell PayPal, keep Pfizer. You are getting paid a pretty good dividend yield waiting for $PFE to turn around. Plus if we have more US interest rates cuts, some risk averse investors will be bidding up the big dividend stocks. $PYPL doesn't pay a dividend and I fail to see a catalyst for a turnaround.

jrex035

Even with the recent announcement I'd hold PFE and offload PYPL, PFE has pays fat dividends and is a better defensive option especially to offset your gains which I imagine are tech heavy

salty0waldo

PFE, ugh. Great.

Ithinktoodeep55

need to offload some of my long term losers to offset my gains: 1) PFE at cost basis 26.86 - stock I bought 18 months ago that has gone nowhere, but still pays a good dividend. they just accounced lowering of their EPS forecast from 2.8-3.0 for FY26, below analyst estimates of 3.08. despite the forward PE remaning at around 9, I think the street is going to respond poorly to this news. I just don't see this stock moving at all next year. 2) Paypal Stock at cost basis 70.85 and Paypal June 80 dollar call options - branded checkout growth stalling, user growth stalling, I just don't see a bright future at all for this stock - even if the EPS continues to improve just due to share buybacks and modest margin increases. thoughts?

MichaelJamesBurry

PFE on discount